ESR1 and breast cancer: In addition, LATS kinases can suppress breast cancer by promoting the ubiquitination and degradation of ERα as well as inhibiting the differentiation of bipotent luminal progenitors, a proposed cellular origin of human breast cancers (Britschgi et al., 2017).